News Leqembi still too pricey, says ICER in updated review Side effects create 'uncertainties' as to whether lecanemab's benefits exceed its risks.
News GSK wins the vote contest in FDA’s RSV vaccine panels Advisory committee votes unanimously that RSVPreF3 shot is effective, and 10-2 on safety.
News Ex-NHS chief negotiator joins Newmarket Strategy Pharma veteran Blake Dark joins the healthcare and life sciences consultancy as senior partner.
News FDA rejects Cytokinetics’ heart failure drug Firm will request a meeting with FDA, but may have to switch focus to folow-up drug aficamten.
News Pfizer’s RSV shot clears FDA adcomm; now it’s GSK’s turn There was debate about cases of Guillain Barré and the population of the phase 3 RENOIR trial.
News Santhera shores up funding ahead of vamorolone verdict The FDA is due to deliver a verdict on vamorolone in Duchenne muscular dystrophy in October.
News Simple blood test could aid in global TB fight A blood test for tuberculosis that can distinguish between dormant and active infections has shown promise in a clinical trial.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
